The Company will apply for listing of the Bonds on the Corporate Bond list at Nasdaq Stockholm. The Bonds will be admitted to trading at Nasdaq Stockholm as soon as possible.
In connection with this, the Company has prepared a prospectus. The prospectus has been approved by, and registered with, the Swedish Financial Supervisory Authority in accordance with Regulation (EU) 2017/1129 of 14 June 2017 of the European Parliament and of the Council. The prospectus will be available on the Financial Supervisory Authority’s website (www.fi.se) and on the Company’s website (www.cambiogroup.com).
This information is information that Sanolium AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 16:00 CEST on 17 August 2020.